JENNA RANDALL: Open Payments
NPI 1619701927 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $111 · 2025 $479
Food & beverage: $380Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $114 |
| ABBVIE INC. | 4 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| Intercept Pharmaceuticals, Inc. | 2 | $49 |
| Ipsen Biopharmaceuticals, Inc | 2 | $47 |
| Lilly USA, LLC | 2 | $35 |
| Madrigal Pharmaceuticals | 1 | $31 |
| Ardelyx, Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
Products named: TREMFYA, XIFAXAN, OCALIVA, IQIRVO, LINZESS, OMVOH, CREON, REZDIFFRA.
Industry payments across NY — which companies pay providers there.
